TRON Stablecoin Transfers Hit $2.21T as TRX ETF Debuts

| newsbtc.com
TRON processed about $2.21 trillion in stablecoin transfers in Q3 2026, up 5.1% from Q2 and accounting for roughly 73% of blockchain stablecoin transfer volume, according to the later report. The network recorded 1.10 billion transactions, up 33.7% year on year but nearly flat quarter on quarter. USDT supply on TRON reached a record $92.7 billion, while combined USDT and USDD supply rose 5.5% to $93.88 billion; TRON’s share of the total USDT market peaked at 50.6%. Average monthly active addresses grew 9.8% to 18 million. TRON also led crypto-card payments with $638 million in volume. Reported DeFi TVL rose 26.6% quarter on quarter to $5.7 billion, while a broader measure including staking put total value locked at $28.21 billion. Network fees fell 4% to $701.4 million. Institutional access expanded with the September debut of the first U.S. spot staked TRX ETF and Anchorage Digital’s addition of TRX staking and TRC-20 custody. The data point to growing TRON use for stablecoin settlement, payments and DeFi, but rising activity does not guarantee an immediate TRX price increase. Q4 will be the ETF’s first full trading quarter.
Neutral
The data are supportive of TRON’s long-term utility: stablecoin transfer volume, USDT supply, active addresses and payment activity all indicate substantial network use, while the ETF launch and new institutional services could broaden access to TRX. These developments may improve sentiment and support demand over time. However, the Q3 transaction count was nearly unchanged from Q2, network fees declined, and the reported TVL figures use different scopes. More importantly, activity and institutional access do not establish direct or immediate buying pressure for TRX. In the short term, traders may react positively to the adoption and ETF headlines, but price action is likely to remain dependent on broader market conditions and actual fund demand. The first full quarter of ETF trading in Q4 may provide a clearer signal; on the available evidence, the direct price impact is neutral.